526 related articles for article (PubMed ID: 15523350)
41. The treatment of psoriasis vulgaris: 1% topical methotrexate gel.
Eskicirak B; Zemheri E; Cerkezoglu A
Int J Dermatol; 2006 Aug; 45(8):965-9. PubMed ID: 16911386
[TBL] [Abstract][Full Text] [Related]
42. Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment.
Wollenberg A; Reitamo S; Atzori F; Lahfa M; Ruzicka T; Healy E; Giannetti A; Bieber T; Vyas J; Deleuran M;
Allergy; 2008 Jun; 63(6):742-50. PubMed ID: 18445188
[TBL] [Abstract][Full Text] [Related]
43. Systemic tacrolimus (FK 506) is effective for the treatment of psoriasis in a double-blind, placebo-controlled study. The European FK 506 Multicentre Psoriasis Study Group.
Arch Dermatol; 1996 Apr; 132(4):419-23. PubMed ID: 8629845
[TBL] [Abstract][Full Text] [Related]
44. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
[TBL] [Abstract][Full Text] [Related]
45. Multicentre, phase II trial on the safety and efficacy of topical tacrolimus ointment for the treatment of lichen sclerosus.
Hengge UR; Krause W; Hofmann H; Stadler R; Gross G; Meurer M; Brinkmeier T; Frosch P; Moll I; Fritsch P; Müller K; Meykadeh N; Marini A; Ruzicka T; Gollnick H
Br J Dermatol; 2006 Nov; 155(5):1021-8. PubMed ID: 17034535
[TBL] [Abstract][Full Text] [Related]
46. Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis.
Bieber T; Vick K; Fölster-Holst R; Belloni-Fortina A; Städtler G; Worm M; Arcangeli F
Allergy; 2007 Feb; 62(2):184-9. PubMed ID: 17298428
[TBL] [Abstract][Full Text] [Related]
47. Topical calcipotriol in the treatment of intertriginous psoriasis.
Kienbaum S; Lehmann P; Ruzicka T
Br J Dermatol; 1996 Oct; 135(4):647-50. PubMed ID: 8915166
[TBL] [Abstract][Full Text] [Related]
48. An open-label pilot study to evaluate the safety and efficacy of topically applied pimecrolimus cream for the treatment of steroid-induced rosacea-like eruption.
Chu CY
J Eur Acad Dermatol Venereol; 2007 Apr; 21(4):484-90. PubMed ID: 17373975
[TBL] [Abstract][Full Text] [Related]
49. Tacalcitol ointment in the treatment of psoriasis vulgaris: a multicentre, placebo-controlled, double-blind study on efficacy and safety.
Van de Kerkhof PC; Werfel T; Haustein UF; Luger T; Czarnetzki BM; Niemann R; Plänitz-Stenzel V
Br J Dermatol; 1996 Nov; 135(5):758-65. PubMed ID: 8977677
[TBL] [Abstract][Full Text] [Related]
50. Proactive treatment of adult facial seborrhoeic dermatitis with 0.1% tacrolimus ointment: randomized, double-blind, vehicle-controlled, multi-centre trial.
Kim TW; Mun JH; Jwa SW; Song M; Kim HS; Ko HC; Kim MB; Song KH; Lee SK; Seo JK; Lee D; Kim BS
Acta Derm Venereol; 2013 Sep; 93(5):557-61. PubMed ID: 23388687
[TBL] [Abstract][Full Text] [Related]
51. Crisaborole 2% ointment for the treatment of intertriginous, anogenital, and facial psoriasis: A double-blind, randomized, vehicle-controlled trial.
Hashim PW; Chima M; Kim HJ; Bares J; Yao CJ; Singer G; Chen T; Genece J; Baum D; Kimmel GW; Nia JK; Gagliotti M; Lebwohl MG
J Am Acad Dermatol; 2020 Feb; 82(2):360-365. PubMed ID: 31279028
[TBL] [Abstract][Full Text] [Related]
52. Tacrolimus ointment 0.1% alone and in combination with medium-dose UVA1 in the treatment of palmar or plantar psoriasis.
Rivard J; Janiga J; Lim HW
J Drugs Dermatol; 2006 Jun; 5(6):505-10. PubMed ID: 16774101
[TBL] [Abstract][Full Text] [Related]
53. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
54. A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis.
Belsito D; Wilson DC; Warshaw E; Fowler J; Ehrlich A; Anderson B; Strober BE; Willetts J; Rutledge ES
J Am Acad Dermatol; 2006 Jul; 55(1):40-6. PubMed ID: 16781290
[TBL] [Abstract][Full Text] [Related]
55. Treatment of localized lesions of canine atopic dermatitis with tacrolimus ointment: a blinded randomized controlled trial.
Bensignor E; Olivry T
Vet Dermatol; 2005 Feb; 16(1):52-60. PubMed ID: 15725106
[TBL] [Abstract][Full Text] [Related]
56. Topical treatment of mild to moderate plaque psoriasis with 0.3% tacrolimus gel and 0.5% tacrolimus cream: the effect on SUM score, epidermal proliferation, keratinization, T-cell subsets and HLA-DR expression.
Vissers WH; van Vlijmen I; van Erp PE; de Jong EM; van de Kerkhof PC
Br J Dermatol; 2008 Apr; 158(4):705-12. PubMed ID: 18284400
[TBL] [Abstract][Full Text] [Related]
57. Inefficacy of topical thyroid hormone analogue TriAc in plaque psoriasis: results of a double-blind placebo-controlled trial.
Vahlquist A; Törmä H; Carlsson B
Br J Dermatol; 2004 Aug; 151(2):489-91. PubMed ID: 15327560
[TBL] [Abstract][Full Text] [Related]
58. Comparing clobetasol propionate 0.05% spray to calcipotriene 0.005% betamethasone dipropionate 0.064% ointment for the treatment of moderate to severe plaque psoriasis.
Menter A; Abramovits W; Colón LE; Johnson LA; Gottschalk RW
J Drugs Dermatol; 2009 Jan; 8(1):52-7. PubMed ID: 19180896
[TBL] [Abstract][Full Text] [Related]
59. Tacrolimus ointment in the treatment of occupationally induced chronic hand dermatitis.
Schliemann S; Kelterer D; Bauer A; John SM; Skudlik C; Schindera I; Wehrmann W; Elsner P
Contact Dermatitis; 2008 May; 58(5):299-306. PubMed ID: 18416762
[TBL] [Abstract][Full Text] [Related]
60. Proactive disease management with 0.03% tacrolimus ointment for children with atopic dermatitis: results of a randomized, multicentre, comparative study.
Thaçi D; Reitamo S; Gonzalez Ensenat MA; Moss C; Boccaletti V; Cainelli T; van der Valk P; Buckova H; Sebastian M; Schuttelaar ML; Ruzicka T;
Br J Dermatol; 2008 Dec; 159(6):1348-56. PubMed ID: 18782319
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
